Burundi vs Zambia: Cause of death, by non-communicable diseases, ages 0-4, male
Burundi
8.5%
in 2021
Zambia
8.7%
in 2021
Burundi rank
158th
Zambia rank
157th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Burundi
- Zambia
How they compare
Zambia currently reports 8.7% against 8.5% in Burundi, a difference of 0.2%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Zambia ahead.
Burundi ranks 158th and Zambia ranks 157th of 185 countries.
Across the 3 decades both report, Burundi averaged higher in 1 and Zambia in 2.
Head to head by decade
| Decade | Burundi | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.9% | 3.3% | 0.3% | Zambia |
| 2010s | 8.7% | 7.4% | 1.2% | Burundi |
| 2020s | 8.4% | 8.5% | 0.1% | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Burundi or Zambia?
- Zambia, at 8.7% against 8.5% in Burundi as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Burundi and Zambia?
- 0.2%, with Zambia ahead.
- How many years of comparable data are there for Burundi and Zambia?
- 6 years are reported by both, from 2000 to 2021.
- How do Burundi and Zambia rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Burundi ranks 158th and Zambia ranks 157th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.